Effects of a Progestin on Frequent and/or Prolonged Bleeding With Nexplanon™
Sponsored by Baylor Research Institute
About this trial
Last updated 4 years ago
Study ID
Status
Type
Phase
Placebo
Accepting
Trial Timing
Ended 8 months ago
What is this trial about?
What are the participation requirements?
Inclusion Criteria
- Between the ages of 18-48
- Between ages of 14-17 with parental/guardian permission
- Women desiring placement of Nexplanon™
- Willing to keep a daily symptom calendar
- Keep appointments
- Women not desiring to become pregnant in the next 2 years
Exclusion Criteria
- Known or suspected Pregnancy
- Less than 8weeks postpartum
- Menarche less than two years ago
- Current or past history of thrombosis or thromboembolic disorders
- Hepatic tumors (benign or malignant)
- Active liver disease
- Undiagnosed abnormal genital bleeding
- Undiagnosed headaches
- Known or suspected carcinoma of the breast or personal history of breast cancer
- Hypersensitivity to any of the components in Nexplanon™
- BMI greater than 40
- Depomedroxyprogesterone acetate injection in the previous 12 weeks